SwissBull7 Trading

 VISL Unusual high Volume Possible runner --------------------------------------------------------------------------------------------------------------- SRPT Overreaction:  Link CEO Explains What Went Wrong With Gene-Therapy Trial x

$TOMZ Y/Y Revenue up +590% and growing international Website: TOMI™ Environmental Solutions ----------------------------------------------------------------------------------- $HSTO Easy +20% gain Website: Histogen ----------------------------------------------------------------------------------- $BBIG Acquisitions is our model / Low float ready for super spike with Crypto/Blockchain NEWS Website: Vinco Ventures, Inc. (BBIG) Hidden Crypto-Player Link

 Website:  BOS BOS is a global provider of custom-made intelligent ROBOTS and an integrator of off-the-shelf automation systems for industrial and logistics processes.  BOS also provides supply chain services, mainly for the aerospace and defense industries worldwide. Market Cap: US$ 11M Free Float: 3.8M Founded: 1990 ----------------------------------------------------------------------------------------------------------------------------- Recent News: Dezember:  Announces $2 Million Registered Direct Offering January :  Appoints Vice President for Robotics Sales in North America   Expected NEWS: NEW ACQUISITION  ----------------------------------------------------------------------------------------------------------------------------- Market Cap: US$ 11M Free Float: 3.8M ----------------------------------------------------------------------------------------------------------------------------- Subsidiary:  IMDECOL One Stop Shop: From the conception of the idea until the final imp

STAF Market Cap: 9.4M  Price / Cash: 1.2 SP $0.65 -> PT Gap up to $0.82 (Gain+26%)

 Website:  Atossa Therapeutics   Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossas current focus on breast cancer and COVID-19. Market Cap: 38M Free Float: 25M Debt: None Recent News:  Atossa Announces $20.0 M Underwritten Public Offering Atossa Announces $14.0 M Registered Direct Offering Priced At-The-Market Offering on 08.Dec and 17.Dec.2020 Guess we all know for what they need the money :-) Expected News ( Upcoming 2020 milestones include the following): 1.  PR IMMINENT:  File pre-IND meeting request with FDA for AT-301 nasal spray for potential at-home treatment of COVID-19 ( ER 13.Nov +30 Days = 25th December 2020) (“Our COVID-19 nasal spray program has progressed very well during the quarter, with our Phase 1 study of AT-301 nasal spray demonstrating good safety and tolerability at two different dose levels in both single and multiple dose forms over a 14-day

 Website:  Qudian Inc. Qudian is a leading technology platform empowering the enhancement of online consumer finance experience in  China . The Company's mission is to use technology to make personalized credit accessible to hundreds of millions of young, mobile-active consumers in  China  who need access to small credit for their discretionary spending but are underserved by traditional financial institutions due to lack of traditional credit data or high cost of servicing.  Market Cap: 234M Free Float: 190M Positive cash flow (EPS 0.33$ and growing) and ridiculous low forward P/E (TTM)

Website:  SOS Limited SOS Limited is a high-tech company driven by AI technology in the digital era.  Through big data accumulation, it applies AI and cloud computing technology to provide customers with efficient emergency rescue services and information security services.  The Company focus on large data accumulation, cloud computing, Internet of things, blockchain, and artificial intelligence  Market Cap: 17M Free Float: 7M Outstanding Revenue Growth Expected For Full Year 2020 Based on information available as of today, full year 2020 revenue is expected to be approximately $49.5 million, representing growth of 451% compared to that of 2019 .  Business Outlook 2021 1. The Company expects net revenue growth of approximately 286% for full-year 2021 . 2. In order to become a national provider in China, the Company will continue to pursue an acquisition of a national insurance brokerage agency.